Otter M, Van Berkel T J, Rijken D C
Gaubius Institute TNO, Leiden, The Netherlands.
Thromb Haemost. 1989 Sep 29;62(2):667-72.
In this study, binding and degradation of tissue-type plasminogen activator (t-PA) by the human hepatoma cell line Hep G2 was investigated. Binding at 4 degrees C was time-dependent and reached a maximum after ca. 2 hours. Scatchard analysis of saturation experiments showed about 170,000 high affinity binding sites for t-PA per cell with an apparent Kd of 90 nM. These binding sites were calcium-dependent. Part of the binding to the hepatoma cells was non-saturable, owing to a large amount of low affinity binding sites which are at least partially located on the extracellular matrix of the cells. Competition with mannose- and galactose-terminated glycoproteins had no effect on total binding of 125I-t-PA. Degradation products of 125I-t-PA were found in the supernatant after a short lag phase and then increased linearly for at least 5 hours at 37 degrees C. Degradation could be inhibited by chloroquine, NH4Cl and NaN3. We conclude that the human hepatoma cell line Hep G2 has a specific binding mechanism for t-PA which is not mediated by known carbohydrate receptor systems. Binding is followed by cellular uptake and degradation in the lysosomes.
在本研究中,对人肝癌细胞系Hep G2与组织型纤溶酶原激活剂(t-PA)的结合及降解进行了研究。4℃下的结合呈时间依赖性,约2小时后达到最大值。饱和实验的Scatchard分析表明,每个细胞约有170,000个t-PA的高亲和力结合位点,表观解离常数(Kd)为90 nM。这些结合位点依赖于钙。由于大量低亲和力结合位点至少部分位于细胞外基质上,所以与肝癌细胞的部分结合是不饱和的。用甘露糖和半乳糖末端糖蛋白进行竞争对125I-t-PA的总结合没有影响。在短暂的延迟期后,在37℃下125I-t-PA的降解产物出现在上清液中,然后至少5小时呈线性增加。氯喹、NH4Cl和NaN3可抑制降解。我们得出结论,人肝癌细胞系Hep G2对t-PA具有一种特异性结合机制,该机制不是由已知的碳水化合物受体系统介导的。结合后接着是细胞摄取并在溶酶体中降解。